KIT and aggressive systemic mastocytosis: Such alternative KIT mutations are particularly detected in patients with ASM, MCL, or MC sarcoma (MCS)—these variants are often located in the juxtamembrane domain (JMD), such as KIT p.V560G, or in the ECD of the receptor, such as KIT p.Del419 [92].